FIELD: medicine.
SUBSTANCE: invention relates to laboratory diagnostics, and can be used to assess the risk of formation of anti-HLA antibodies during transfusion of blood components. A comprehensive study of the alleles of the HLA gene loci DRB1, DQA1, DQB1 in recipients is carried out. When the HLA-DRB1*04-DQA1*03:01-DQB1*03:02 haplotype is detected in the genotypes of recipients, a risk of formation of anti-HLA antibodies is assessed as high. When HLA haplotype DRB1*16-DQA1*01:02-DQB1*05:02 is detected in the genotypes of recipients, a risk of formation of anti-HLA antibodies is assessed as low.
EFFECT: effective assessment of the risk of formation of anti-HLA antibodies during transfusion of blood components by identifying predisposing haplotypes of HLA-DR and DQ genes in recipients.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF EXTRACORPOREAL FERTILISATION AND EMBRYO TRANSFER | 2011 |
|
RU2474822C1 |
| HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENT AGENTS THAT TARGET TOXIN B CLOSTRIDIUM DIFFICILE | 2017 |
|
RU2761249C2 |
| METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
| METHOD OF PROGNOSING DEVELOPMENT OF TYPE 1 SUGAR DIABETES IN POPULATIONS OF BASHKORTOSTAN PEOPLES | 2008 |
|
RU2368325C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF DIABETES MELLITUS TYPE 1 IN BASHKORTOSTAN PEOPLE POPULATIONS | 2005 |
|
RU2285921C1 |
| PATIENT-SPECIFIC STEM CELL LINES DERIVED FROM HUMAN PARTHENOGENETIC BLASTOCYSTS | 2008 |
|
RU2511418C2 |
| METHOD FOR PREDICTION OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2441242C1 |
| METHOD OF DETECTING PREDISPOSITION AND RESISTANCE TO DEVELOPMENT OF CYST ECHINOCOCCOSIS IN CHILDREN | 2008 |
|
RU2387383C1 |
| PROBIOTIC COMPOSITIONS AND THEIR APPLICATION | 2018 |
|
RU2763311C2 |
